Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

FRESENIUS SE & CO. KGAA

(FRE)
  Report
Real-time Estimate Tradegate  -  12:18 2022-12-07 pm EST
26.46 EUR   +0.99%
11:06aPharama Stocks Nudge European Equities Modestly Higher in Wednesday Trading
MT
12/06Global markets live: Vodafone, PepsiCo, Microsoft, Implenia, Pfizer...
MS
12/06Fresenius Medical Care CEO Steps Down, Replacement Named
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Xetra
12/01/2022 12/02/2022 12/05/2022 12/06/2022 12/07/2022 Date
26.51(c) 27.05(c) 26.62(c) 26.2(c) 26.44 Last
1 157 900 1 318 459 1 207 762 1 556 939 1 181 028 Volume
-0.19% +2.04% -1.59% -1.58% +0.92% Change
More quotes
Estimated financial data (e)
Sales 2022 40 863 M 42 987 M 42 987 M
Net income 2022 1 628 M 1 713 M 1 713 M
Net Debt 2022 23 713 M 24 945 M 24 945 M
P/E ratio 2022 8,98x
Yield 2022 3,08%
Sales 2023 43 001 M 45 236 M 45 236 M
Net income 2023 1 863 M 1 959 M 1 959 M
Net Debt 2023 21 979 M 23 121 M 23 121 M
P/E ratio 2023 7,93x
Yield 2023 3,43%
Capitalization 14 757 M 15 524 M 15 524 M
EV / Sales 2022 0,94x
EV / Sales 2023 0,85x
Nbr of Employees 319 691
Free-Float 73,0%
More Financials
Company
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.8%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.2%;... 
More about the company
Ratings of Fresenius SE & Co. KGaA
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about FRESENIUS SE & CO. KGAA
11:06aPharama Stocks Nudge European Equities Modestly Higher in Wednesday Trading
MT
12/06Global markets live: Vodafone, PepsiCo, Microsoft, Implenia, Pfizer...
MS
12/06Fresenius Medical Care CEO Steps Down, Replacement Named
MT
12/06European Midday Briefing: Fed Rate Path Fears Dampen Mood Again
DJ
12/06FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Ne..
MD
12/06FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Jefferies..
MD
12/05Fresenius Medical Care CEO Resigns; Finance Chief Named Successor
MT
12/05FMC boss leaves after two months as Fresenius pushes for changes
RE
12/05Germany's FMC appoints Helen Giza as CEO
RE
12/05Helen Giza is the new CEO of Fresenius Medical Care; Dr. Carla Kriwet leaves the compan..
EQ
12/02European Equities Move Lower to End Strong Month, Week Lower
MT
12/01Fresenius : appoints Dennis Hofmann as Head of Corporate Communications
PU
11/30EMEA Morning Briefing: Stocks to Rise as China Covid Policy, Powel..
DJ
11/29FRESENIUS SE : Barclays reiterates its Buy rating
MD
11/29FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Berenberg..
MD
More news
News in other languages on FRESENIUS SE & CO. KGAA
11:06aLes actions de Pharama poussent les actions européennes légèrement à la hausse dans les..
01:31aMORNING BRIEFING - Deutschland/Europa
12/06Städte fordern 'schnell wirkendes Rettungspaket' für Kliniken
12/06Aktien Frankfurt Schluss: Schwung lässt weiter nach
12/06MÄRKTE EUROPA/US-Zinssorgen gehen wieder um - FMC-CEO-Wechsel belastet
More news
Analyst Recommendations on FRESENIUS SE & CO. KGAA
More recommendations
ETFs positioned on FRESENIUS SE & CO. KGAAETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Deka DAXplus Maximum Dividend - EUR7.87%0.02%Germany
Lyxor S&P Eurozone ESG Dividend Aristocrats...2.1%0.44%-NC
SPDR S&P Euro Dividend Aristocrats - EUR1.99%0.44%Europe
First Trust Germany AlphaDEX - EUR1.93%0.16%Germany
Lyxor S&P Eurozone ESG Dividend Aristocrats...1.88%-0.25%-NC
More ETFs positioned on FRESENIUS SE & CO. KGAA
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 26,20 €
Average target price 35,82 €
Spread / Average Target 36,7%
EPS Revisions
Managers and Directors
Michael Sen Chief Executive Officer
Sara Hennicken Chief Financial Officer
Wolfgang Kirsch Chairman-Supervisory Board
Michael Albrecht Independent Member-Supervisory Board
Konrad K÷lbl Member-Supervisory Board
Sector and Competitors